Heat-shock protein expression and topical treatment with tacrolimus in oral lichen planus: an immunohistochemical study.
Oral lichen planus (OLP) is a chronic inflammatory mucosal disease of unknown etiology. Usually asymptomatic, the disorder is occasionally complicated by extensive painful erosions. Topical corticosteroids are the mainstay of treatment, but a new topical therapy with tacrolimus has been described previously. The aim of the current study was to examine the expression of heat-shock protein 70 (HSP70) in biopsy specimens from 11 OLP lesions before and after topical treatment with tacrolimus. Immunostaining was performed with anti-HSP70 antibody as the primary layer. Clinically, there was a rapid improvement with topical tacrolimus treatment in 10 out of the 11 patients. The moderate increase in HSP70 expression after treatment with tacrolimus was not significant. It was concluded that topical tacrolimus has no effect on the expression of HSP70 in OLP.
Tavassol
F
F
Department of Oral and Maxillofacial Surgery, Hanover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany. tavassol.frank@mh-hannover.de
Starke
O F
OF
Völker
B
B
Kokemüller
H
H
Eckardt
A
A
D000287:Administration, Topical; D000368:Aged; D000818:Animals; D005260:Female; D018840:HSP70 Heat-Shock Proteins / Q000032:analysis*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D017676:Lichen Planus, Oral / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects; D011817:Rabbits; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects